Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

23 resultsUpdated October 23, 2026

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

The Lancet Diabetes & Endocrinology 7(7) (2019)

Ofri Mosenzon; Thalia Marie Blicher; Signe V. Rosenlund; Jan W. Eriksson; Simon R. Heller; Ole Holm Hels; Richard E. Pratley; Thozhukat Sathyapalan; Cyrus V Desouza; Rosane Ness-Abramof; Diana Alpenidze; S Aronoff; K. Astamirova; B Barker; Gary Bedel; Lidia Belousova; M Benson; Isaac Beshay; WILLIAM C. BIGGS; Kenneth Blaze; Paweł Bogdański; Robert S. Busch; Sushela Chaidarun; S Chandran; Alex R. Chang; S Chilka; A Cleland; Lisa E. Connery; George Mitchell Cornett; B Delgado; Cyrus V Desouza; Thomas W. Donner; Ken Eliasson; Jan W. Eriksson; Steven Folkerth; K Forshaw; Hans Frandsen; Elena Frolova; Winston Gandy; G Gatipon; Головач Альбина Вячеславовна; Luis Gonzalez-Orozco; Janusz Gumprecht; E Haddad; Troels Krarup Hansen; Thomas C. Hart; S Hasan; Brent Hella; Simon R. Heller; M Hellgren; M Hewitt; S Hietaniemi; M Hitz; P Houser; Raphael E. Huntley; R Jackson; Poul Erik Jakobsen; A Kapoor; Л. В. Каргина; Elena E. Kazakova; Khalid Javeed Khan; ERIC J. KLEIN; H Knoble; N Krasnopeeva; Andre Krzeminski; М. А. Куницына; J Lawhead; K Levin; P Levin; Lorena Lewy-Alterbaum; Stina Lindmark; Robert S. Lindsay; A Luts; Tatyana A. Lysenko; Sten Madsbad; T Maxwell; Caroline N. Mbogua; JA McKnight; Kaj Peter Metsarinne; Т. А. Милованова; Emily J. Morawski; Ofri Mosenzon; Dan Nabriski; Hai Quy Tram Nguyen; Philip Nicol; Sanna Nieminen; Anita Schwab Nikkola; Paul C. Norwood; Peter H. O’Donnell; A. Ola Odugbesan; J Parker; Y. Pergaeva; A Peskov; S Plevin; Joe Pouzar; Richard E. Pratley; Josh Reed; Peter R Rossing; Thozhukat Sathyapalan; Marina Y. Sergeeva-Kondrachenko

SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD

Endocrinology 162(12) (2021)

Moein Ala

Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review

Foods 11(14) (2022)

Daniel Jamrozik; Weronika Borymska; Ilona Kaczmarczyk-Żebrowska

Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction

Journal of Cardiac Failure 25(12) (2019)

Milton Packer

The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis

Contemporary Clinical Trials Communications 28 (2022)

Yousef Alhindi; Amanda Avery

A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey

Cardiovascular Endocrinology & Metabolism 9(1) (2020)

Mitra Mosslemi; Hannah L. Park; Christine E. McLaren; Nathan D. Wong

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019

Diabetes & Metabolism Journal 47(2) (2023)

Jiyun Park; Gyuri Kim; Bongsung Kim; Kyungdo Han; So Yoon Kwon; Sohee Park; You‐Bin Lee; Sang‐Man Jin; Jae Hyeon Kim

Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential

Obesity Reviews 26(7) (2025)

Zhongwen Qi; Dan Wu; Zhipeng Yan; Qing Wang; Yiming Li; Junnan Zhao; Fengqin Xu

Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

PLoS ONE 17(5) (2022)

Ashenafi Kibret Sendekie; Achamyeleh Birhanu Teshale; Yonas Getaye Tefera

Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

International Journal of Diabetes in Developing Countries 43(6) (2023)

Ashok Kumar Das; Banshi Saboo; Rajeev Chawla; S R Aravind; Rajesh Rajput; Awadhesh Kumar Singh; Jagat Jyoti Mukherjee; Ashok Kumar Jhingan; Parag Shah; Vaishali Chetan Deshmukh; Shailaja C. Kale; Shalini Jaggi; G. R. Sridhar; Rajnish Dhediya; Kumar Gaurav

Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study

BMJ Open Diabetes Research & Care 11(2) (2023)

Akihiro Kudo; Noritaka Machii; Toshio Ono; Haruka Saito; Yoshito Oshiro; Ryu Takahashi; Koichi Oshiro; Yoshinobu Taneda; Moritake Higa; Ken Nakachi; Shusuke Yagi; Hiroaki Masuzaki; Masataka Sata; Michio Shimabukuro

Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study

PLoS ONE 19(11) (2024)

Nadia Gul; Inayat Ur Rehman; Yasar Shah; Arbab Muhammad Ali; Zahid Ali; Omer Shehzad; Khang Wen Goh; Long Chiau Ming; Amal Khalil Suleiman

Hypoglycemic Effect of Calendula arvensis Flowers is Mediated by Digestive Enzyme Inhibition

Current Bioactive Compounds 16(5) (2019)

Abdul-Malik Abudunia; Ilias Marmouzi; Mourad Kharbach; Meryem El Jemli; Karima Sayah; Abdelhakim Bouyahya; Ali Gamal Al-Kaf; Ali A. Alyahawi; M’hammed Ansar; Abdelaziz Bouklouze; My El Abbés Faouzi; Azeddine Ibrahimi

Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis

Diabetes Research and Clinical Practice 174 (2021)

Maximilian Gabler; Nils Picker; Silke Geier; Johannes Foersch; Jens Aberle; Stéphan Martin; Matthias Riedl; Thomas Wilke

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients

Saudi Pharmaceutical Journal 28(2) (2019)

Sirajudeen Shaik Alavudeen; Moteb A. Khobrani; C. K. Dhanapal; Javid Iqbal Mir; Sultan Mohammed Alshahrani; Noohu Abdullah Khan; Abdulaziz Alhossan

Les inhibiteurs des SGLT2 : traitement anti diabétiques et/ou de la prévention cardiovasculaire et/ou protection rénale ? Place au débat

Archives of Cardiovascular Diseases Supplements 11 (2019)

Michel Krempf

Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non‐interventional comparative study

International Journal of Clinical Practice 75(3) (2020)

Sirajudeen Shaik Alavudeen; Sultan Mohammed Alshahrani; Vigneshwaran Easwaran; Noohu Abdulla Khan; Javid Iqbal Mir; Abubakr Taha Hussein

Anestesia y diabetes en el perioperatorio

Anales Médicos de la Asociación Médica del Centro Médico ABC 66(3) (2021)

Angélica Yanine López Ramírez; Norma Elizabeth Carrillo Molina; Jaime Pablo Antonio Ortega García

Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Frontiers in Pharmacology 17 (2026)

Yuanyuan Zhong; Xing Tan; Ling Zhang; Cangui Wu